Alternative Lymphodepletion Strategies Lead to Similar Response Rates and Toxicities in Standard-of-Care BCMA-Directed CAR-T Therapy in Relapsed Refractory Multiple Myeloma

Midha, S., Gurumurthi, A., Costello, P., Redd, R. A., Freeman, C. L. L., Castaneda, O., Gonzalez, R., Ionescu, F., Gaballa, M., Kalariya, N., Khouri, J., Dima, D., Kocoglu, M. H., Sborov, D., Wagner, C. B., Atrash, S., Voorhees, P. M., Hashmi, H., Davis, J. A., … Patel, K. K. (2023). Alternative Lymphodepletion Strategies Lead to Similar Response Rates and Toxicities in Standard-of-Care BCMA-Directed CAR-T Therapy in Relapsed Refractory Multiple Myeloma. Blood, 142(Supplement 1), 3499–3499. https://doi.org/10.1182/blood-2023-187565
Authors:
Shonali Midha
Ashwath Gurumurthi
Patrick Costello
Robert Redd
Ciara L. Freeman
Omar Castaneda
Rebecca Gonzalez
Filip Ionescu
Mahmoud Gaballa
Nilesh Kalariya
Jack Khouri
Danai Dima
Mehmet H. Kocoglu
Douglas W. Sborov
Charlotte B Wagner
Shebli Atrash
Peter M. Voorhees
Hamza Hashmi
James A. Davis
Peter A. Forsberg
Joseph P. McGuirk
Leyla Shune
Megan M. Herr
Ran Reshef
Yi Lin
Myo Htut
Thomas Martin
Surbhi Sidana
Doris K. Hansen
Omar Nadeem
Krina K. Patel
Affiliated Authors:
Ran Reshef
Columbia Affiliation:
Subjects:
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
Immunogenicity of Biosimilar Therapeutics in Drug Development (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2023-187565
DOI:
10.1182/blood-2023-187565
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: